Ferric Carboxymaltose Inj/IV, Iron Isomaltoside inj/ IV, Heparin, Citicoline, Fluphenazine, Haloperidol, Levetiracetam, Iron Polymaltose Inj,L-Ornithine L-Aspartate Injections

Ferric Carboxymaltose Inj/IV, Iron Isomaltoside inj/ IV, Heparin, Citicoline, Fluphenazine, Haloperidol, Levetiracetam, Iron Polymaltose Inj,L-Ornithine L-Aspartate Injections
Product Description

Hematinic Injectables-Ferric Carboxymaltose Inj/IV (50 mg per ml)- treats anemia (Leads to Instant Hemoglobin rise with No Anaphylactic Shock,Highest Patient Compliance,Highest Safety Profile amongst all the Intravenous hematinic,Widely recommended for Critical Care Patients under CKD, Cardio-vascular Disease, Diabetic and Gynae Segments Lower dosage requirement), Iron Isomaltoside inj/ IV (100 mg per ml) and Iron Polymaltose (III) hydroxide Inj (50 mg per ml), Anti-coagulant- Heparin Inj (1000/ IU per ml and 5000 IU per ml), Citicoline-treats tstroke, head trauma or injury, Alzheimer's disease, Parkinson's disease, and glaucoma, Fluphenazine, Haloperidol Inj- Indicated for schizophrenia, Levetiracetam Inj- Indicated for epilepsy and seizures, L-Ornithine L-Aspartate Injection-treat liver diseases such as acute and chronic hepatitis, chronic alcoholic liver damage, fatty liver, jaundice, liver cirrhosis, and non-alcoholic steatohepatitis

Eskag Pharma Pvt Ltd

  • IN
  • 2016
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
OTC
Other
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Hematinic Injectables-Ferric Carboxymaltose Inj/IV (50 mg per ml)- treats anemia (Leads to Instant Hemoglobin rise with No Anaphylactic Shock,Highest Patient Compliance,Highest Safety Profile amongst all the Intravenous hematinic,Widely recommended for Critical Care Patients under CKD, Cardio-vascular Disease, Diabetic and Gynae Segments Lower dosage requirement), Iron Isomaltoside inj/ IV (100 mg per ml) and Iron Polymaltose (III) hydroxide Inj (50 mg per ml), Anti-coagulant- Heparin Inj (1000/ IU per ml and 5000 IU per ml), Citicoline-treats tstroke, head trauma or injury, Alzheimer's disease, Parkinson's disease, and glaucoma, Fluphenazine, Haloperidol Inj- Indicated for schizophrenia, Levetiracetam Inj- Indicated for epilepsy and seizures, L-Ornithine L-Aspartate Injection-treat liver diseases such as acute and chronic hepatitis, chronic alcoholic liver damage, fatty liver, jaundice, liver cirrhosis, and non-alcoholic steatohepatitis
  • Model
    Ferric Carboxymaltose Inj/IV, Iron Isomaltoside inj/ IV, Heparin, Citicoline, Fluphenazine, Haloperidol, Levetiracetam, Iron Polymaltose Inj,L-Ornithine L-Aspartate Injections
  • Supplied from
    India

Eskag Pharma Pvt Ltd

  • IN
  • 2016
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
OTC
Other
Pharmaceutical Company (generic finished products)

More Products from Eskag Pharma Pvt Ltd (9)

Eskag Pharma Pvt Ltd resources (1)

  • Brochure Product List

    Eskag Pharma is a global player of speciality generics from its ultra modern facilities that are WHO-GMP certified and offers a comprehensive basket of new and innovative formulations like Dydrogesterone tablet, PEG alone and in combination liquid, Liposomal Iron, Sucralfate with Mupirocin crème, Ferric Carboxymaltose and Iron Isomaltoside as Haematinic Injectables, DCGI approved anti-hyperglycemic medications like Sitagliptin and dapagliflozin tablet, Metformin Syrup along with One of its kind Medical device to name a few.We are seeking cooperation in Contract manufacturing-both India and abroad, JV,Tech Transfer.